Skip to content

Supplier News

Teva to buy Cephalon

Teva Pharmaceutical Industries Ltd. plans to acquire Cephalon Inc. in a $6.8 billion cash deal. The pharmaceutical companies said Monday that the $81.50-per-share acquisition agreement, pending regulatory and shareholder approvals, is expected to close in the third quarter.

Leo Pharma enhances Taclonex website

Leo Pharma Inc. has gone live with an expanded website for its Taclonex topical medications for psoriasis. The company said Thursday that updates to the www.taclonex.com site include the addition of product information for both Taclonex Ointment (calcipotriene 0.

PEZ adds combo flavors to candy lineup

PEZ Candy Inc. has added two new flavors, Strawberry-Vanilla and Raspberry-Lemon. The company said Wednesday that the new flavors are the first blends of the dispenser candy to be launched in the United States.

Children’s AccuDial honored for innovation

Children’s AccuDial, a line of over-the-counter pediatric medicines from AccuDial Pharmaceutical Inc., has been named a 2011 Edison Awards winner. AccuDial said Wednesday that its product line won gold in the Consumer Packaged Goods segment, one of 12 categories honored by the Edison Awards.

New CEO to take helm at MillerCoors

Tom Long has been appointed chief executive officer of MillerCoors, whose current CEO, Leo Kiely, is slated to retire in the coming weeks. The company, a U.S. joint venture of SABMiller plc and Molson Coors Brewing Co.

100% Natural Lipton Iced Tea line makes debut

Lipton Iced Tea is launching 100% Natural Lipton Iced Tea, a new line of beverages with a simple, all-natural ingredient list. The Pepsi Lipton Tea Partnership said Tuesday that 100% Natural Lipton Iced Tea will be available in four flavors — Green Tea with Citrus, Iced Tea with Lemon, Iced Tea with

Watson’s Crinone added to fertility Rx card program

Watson Pharmaceuticals Inc.’s Crinone 8% progesterone gel is now included in New Life Agency Inc.’s Fertility Pharmacy Care Card program, which provides prescription drug discounts to fertility patients through Walgreens Specialty Pharmacy.

Breast cancer generic released by Mylan

Mylan Pharmaceuticals Inc. has begun shipping letrozole tablets 2.5 mg, a treatment for postmenopausal women with early-stage breast cancer. Parent company Mylan Inc. said Monday that it launched the product under a previously announced settlement and license agreement with Novartis.

HDMA: Specialty Rx distributors save billions in costs

Distributors of specialty pharmaceuticals save the health care industry billions of dollars annually via efficient, extensive measures to ensure their safe delivery, according to new research from the Healthcare Distribution Management Association (HDMA).